Covid-19 positive donor utilization for heart transplantation: The new frontier for donor pool expansion.


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
08 2023
Historique:
revised: 26 05 2023
received: 11 04 2023
accepted: 30 05 2023
medline: 14 8 2023
pubmed: 12 6 2023
entrez: 12 6 2023
Statut: ppublish

Résumé

Hearts from COVID-19 positive donors (CPD) are being utilized for heart transplantation by some centers; however, this is in the setting of the lack of guidelines or robust evidence. The paucity of evidence is reflected in the recent Organ Procurement and Transplantation Network (OPTN) communication describing CPD utilization as an "unknown risk." We analyzed the UNOS database for adult heart transplants performed between January 2021 to December 2022, and CPD comprised of a significant percentage of donors, being used in >10% of recipients in some UNOS regions. Between July 2022 and December 2022, 7.9% of heart transplants were with CPD, and in the same period Hepatitis C positive donors accounted for 7.1% and donation after circulatory death (DCD) accounted for 10.3%. If the transplant community comes up with a standardized approach and guidance in using CPD hearts, this could provide an effective donor pool expansion strategy.

Sections du résumé

BACKGROUND
Hearts from COVID-19 positive donors (CPD) are being utilized for heart transplantation by some centers; however, this is in the setting of the lack of guidelines or robust evidence. The paucity of evidence is reflected in the recent Organ Procurement and Transplantation Network (OPTN) communication describing CPD utilization as an "unknown risk."
METHODS AND RESULTS
We analyzed the UNOS database for adult heart transplants performed between January 2021 to December 2022, and CPD comprised of a significant percentage of donors, being used in >10% of recipients in some UNOS regions. Between July 2022 and December 2022, 7.9% of heart transplants were with CPD, and in the same period Hepatitis C positive donors accounted for 7.1% and donation after circulatory death (DCD) accounted for 10.3%.
CONCLUSION
If the transplant community comes up with a standardized approach and guidance in using CPD hearts, this could provide an effective donor pool expansion strategy.

Identifiants

pubmed: 37306941
doi: 10.1111/ctr.15046
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15046

Informations de copyright

© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Gaurang Nandkishor Vaidya (GN)

Department of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky, USA.

Paul Anaya (P)

Department of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky, USA.

Maya Ignaszewski (M)

Department of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky, USA.

Andrew Kolodziej (A)

Department of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky, USA.

Rajasekhar Malyala (R)

Department of Cardiothoracic Surgery, University of Kentucky, Lexington, Kentucky, USA.

Navin Rajagopalan (N)

Department of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky, USA.

Michael Sekela (M)

Department of Cardiothoracic Surgery, University of Kentucky, Lexington, Kentucky, USA.

Emma Birks (E)

Department of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH